Supplementary Figures 1 - 6, Tables 1 - 3 from Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An In Vivo Study in Orthotopic Xenografts of Nude Mice
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 1679K, S Figure 1. Anti-miR-182 treatment for cell proliferation and invasion in normal and malignant ovarian cell lines in vitro. S Figure 2. Photomicrographs illustrating the surgical procedures of Orthotopic mouse model of ovarian cancer. S Figure 3. The general information of mice with anti-miR-182 treatment. S Figure 4. LIN28B, MYCN, and CA125 expression in mice with and without anti-miR-182 treatment. S Figure 5. Metastatic carcinomas in spleen and omentum. S Figure 6. Some miR-182 predicted target gene expression in mice with and without anti-miR-182 treatment. S Table 1. Primers and sequences used in this study. S Table 2. Antibody information used in this study. S Table 3. Metastasis analysis in mice with and without anti-miR-182 treatment.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362493937